EBITDA

NAMSA appoints commercial leader Scott Day as VP, signaling a strategic push to expand its end-to-end clinical and consulting services amid industry growth.

Menē Inc. celebrates its first profitable year, but soaring gold prices create a new challenge: attracting new buyers to its unique investment-grade jewelry.

Ionic Digital's Bitcoin output fell in March, but a debt-free strategy and a major AI deal suggest a calculated shift toward long-term stability.

VoIP giant Zadarma launches a fully Italian platform, including an AI voice agent, aiming to capture a key European market with deep localization.

With a new 17,000 sq ft facility, an Idaho tech firm is scaling its revolutionary 3D printing to meet surging aerospace and defense composite demand.

A major Shanghai education festival tackles AI's threat to jobs and a youth mental health crisis, forging new paths for international collaboration.

The Irish firm lands a key ESA contract for its "universal translator" tech, paving the way for a unified, high-speed internet across satellite networks.

A landmark study identifies five key carbon capture hubs in Asia-Pacific, as steel and energy giants expand their alliance to tackle industrial emissions.

After a decade as Semaphore Solutions, Labbit is going all-in on its LIMS platform. Here’s why the strategic shift matters for regulated laboratories.

Sobeys is investing $51M to digitize shelves across Canada. This move signals a major shift in the grocery wars, promising new efficiencies and a smarter shopping experience.

A new gene therapy that reprograms cancer cells into immune activators shows major promise, blending personalized treatment with off-the-shelf convenience.

Adobe's Frame.io leverages Suite Studios' streaming tech to make cloud files act like local drives, aiming to eliminate downloads and revolutionize remote work.

Beyond aesthetics, a new office philosophy emerges where space performs. Stella33's Milan project shows how human-centric design can unlock potential.

With new EU eco-design rules looming, Glimpact's funding from Sparkalis signals a major shift toward data-driven sustainability in the agri-food industry.

Presented at AACR 2026, first-in-class antibody IMT-009 shows clinical benefit in tough cancers, potentially paving the way for a new precision therapy.

New data on ATX-295 reveals a potent attack on unstable tumors, guided by an AI biomarker that could change how we select patients for treatment.

Newcomer Capital-FORCE makes a strategic entry into the competitive ETF space by acquiring two established IBD-branded funds from Innovator.

Nested Therapeutics' NST-628 reports a 38% response rate in advanced melanoma, offering new hope with a novel, brain-penetrating cancer-fighting agent.

An appeals court strikes down a Los Angeles ordinance on relocation fees but upholds eviction rules, reshaping the legal landscape for landlords and tenants.

A surprise $5 million pledge for glaucoma research highlights a gala honoring philanthropist Daria Barry, patient advocate Hillary Golden, and music icon Nile Rodgers.